The Lancet Psychiatry in conversation with
Un podcast de The Lancet Group
106 Épisodes
-
Ian Wong on methylphenidate for children and adolescents with ADHD
Publié: 24/03/2023 -
Afarin Rahimi-Movaghar on drug use and treatment services in the Eastern Mediterranean
Publié: 24/02/2023 -
Richard Morriss on cranial electrostimulation therapy for depression
Publié: 29/01/2023 -
Protection or Paternalism?
Publié: 16/12/2021 -
Wellcome Global Monitor
Publié: 20/10/2021 -
Cultural Competency
Publié: 23/09/2021 -
ECT safety
Publié: 12/07/2021 -
Debbie Challis on helping children deal with the aftermath of COVID-19
Publié: 20/05/2021 -
Erica Crompton on the importance of first-person stories
Publié: 10/03/2021 -
Michael Wright on mental health in Aboriginal communities
Publié: 09/02/2021 -
Kimberly Sue on increasing access to buprenorphine
Publié: 22/01/2021 -
Youth work environments
Publié: 11/12/2020 -
Off-radar youth
Publié: 09/12/2020 -
If a patient dies by suicide
Publié: 19/11/2020 -
Life After Suicide
Publié: 03/09/2020 -
Safe Injection Sites
Publié: 13/08/2020 -
Psychological therapies in first-onset psychosis
Publié: 08/07/2020 -
The Connection Coalition
Publié: 25/06/2020 -
Active ingredients
Publié: 19/06/2020 -
Rikers Island
Publié: 21/05/2020
Sophia Davis, Senior Editor at The Lancet Psychiatry, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from premature mortality in people with mental illness to cranial electrostimulation therapy for depression, the importance of first-person stories to psychological therapy for sleep problems in young people at risk of psychosis, and more.